Racial Disparity in CSF Amyloid and Tau Biomarkers in Mild Cognitive Impairment

This case-control study compares cerebrospinal fluid (CSF) amyloid and tau biomarkers for Alzheimer disease in African American and white individuals with normal cognition and with mild cognitive impairment.

Read the full article here

Related Articles